XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Proportionate Voting Shares
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   95,342 67,418,174    
Balance at Dec. 31, 2019 $ 123,996   $ 1 $ 144,206 $ (20,211)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)     3,987,035    
Exercise of stock options 2,467     2,467  
Conversion to common shares (in shares)   (16,140) 6,455,826    
Withholding of common shares upon vesting of restricted share awards (in shares)     32,801    
Withholding of common shares upon vesting of restricted share units (19)     (19)  
Share-based compensation 3,149     3,149  
Harmony Hemp contingent equity compensation (in shares)     114,696    
Harmony Hemp contingent equity compensation 1,177     1,177  
Share offering, net of warrants and issuance costs (in shares)     11,500,000    
Share offering, net of warrants and issuance costs 44,591     44,591  
Abacus acquisition (in shares)   1,975 17,551,705    
Abacus acquisition 109,562     109,562  
Net loss and comprehensive loss (30,681)       (30,681)
Balance (in shares) at Dec. 31, 2020   81,177 107,060,237    
Balance at Dec. 31, 2020 $ 254,242   $ 1 305,133 (50,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares) 8,261   8,261    
Exercise of stock options $ 30     30  
Conversion to common shares (in shares)   (81,177) 32,471,060    
Exercise of warrants (in shares)     98,788    
Exercise of warrants 441     441  
Withholding of common shares upon vesting of restricted share awards (in shares)     182,727    
Withholding of common shares upon vesting of restricted share units (146)     (146)  
Share-based compensation 4,023     4,023  
Harmony Hemp contingent equity compensation (in shares)     338,091    
Harmony Hemp contingent equity compensation 1,460     1,460  
Share offering, net of warrants and issuance costs (in shares)     4,500,800    
Share offering, net of warrants and issuance costs 8,118     8,118  
Net loss and comprehensive loss (137,722)       (137,722)
Balance (in shares) at Dec. 31, 2021   0 144,659,964    
Balance at Dec. 31, 2021 $ 130,446   $ 1 $ 319,059 $ (188,614)